BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 31607194)

  • 1. Adiponectin reduces brain injury after intracerebral hemorrhage by reducing NLRP3 inflammasome expression.
    Wang S; Yao Q; Wan Y; Wang J; Huang C; Li D; Yang B
    Int J Neurosci; 2020 Mar; 130(3):301-308. PubMed ID: 31607194
    [No Abstract]   [Full Text] [Related]  

  • 2. Cordycepin confers neuroprotection in mice models of intracerebral hemorrhage via suppressing NLRP3 inflammasome activation.
    Cheng Y; Wei Y; Yang W; Song Y; Shang H; Cai Y; Wu Z; Zhao W
    Metab Brain Dis; 2017 Aug; 32(4):1133-1145. PubMed ID: 28401330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury.
    Xu X; Yin D; Ren H; Gao W; Li F; Sun D; Wu Y; Zhou S; Lyu L; Yang M; Xiong J; Han L; Jiang R; Zhang J
    Neurobiol Dis; 2018 Sep; 117():15-27. PubMed ID: 29859317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective NLRP3 (Pyrin Domain-Containing Protein 3) Inflammasome Inhibitor Reduces Brain Injury After Intracerebral Hemorrhage.
    Ren H; Kong Y; Liu Z; Zang D; Yang X; Wood K; Li M; Liu Q
    Stroke; 2018 Jan; 49(1):184-192. PubMed ID: 29212744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of MCC950 on nerve injury in rats with intracerebral hemorrhage].
    Guo YJ; Ren J; Liu H; Li TT; Zhang S; Wang H
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Jan; 38(1):11-16. PubMed ID: 35634663
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke.
    Ismael S; Zhao L; Nasoohi S; Ishrat T
    Sci Rep; 2018 Apr; 8(1):5971. PubMed ID: 29654318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MCC950 Inhibits NLRP3 Inflammasome and Alleviates Axonal Injures in Early Stages of Diffuse Axonal Injury in Rats.
    Zhao J; Guo X; Wang B; Yang Z; Huang T; Guo D; Zhang M; Song J
    Neurochem Res; 2020 Sep; 45(9):2020-2031. PubMed ID: 32474832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MCC950 attenuated early brain injury by suppressing NLRP3 inflammasome after experimental SAH in rats.
    Luo Y; Lu J; Ruan W; Guo X; Chen S
    Brain Res Bull; 2019 Mar; 146():320-326. PubMed ID: 30716395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Edaravone Administration Confers Neuroprotection after Experimental Intracerebral Hemorrhage in Rats via NLRP3 Suppression.
    Miao H; Jiang Y; Geng J; Zhang B; Zhu G; Tang J
    J Stroke Cerebrovasc Dis; 2020 Jan; 29(1):104468. PubMed ID: 31694784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the NLRP3 inflammasome reduces brain edema and regulates the distribution of aquaporin-4 after cerebral ischaemia-reperfusion.
    Wang H; Chen H; Jin J; Liu Q; Zhong D; Li G
    Life Sci; 2020 Jun; 251():117638. PubMed ID: 32251636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of NLRP3 inflammasome blockade on postresuscitation cerebral function in a rat model of cardiopulmonary resuscitation.
    Zheng G; Xu J; He F; Hu J; Ge W; Ji X; Wang C; Bradley JL; Peberdy MA; Ornato JP; Toldo S; Wang T; Tang W
    Biomed Pharmacother; 2021 Nov; 143():112093. PubMed ID: 34474352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glibenclamide ameliorates the disrupted blood-brain barrier in experimental intracerebral hemorrhage by inhibiting the activation of NLRP3 inflammasome.
    Xu F; Shen G; Su Z; He Z; Yuan L
    Brain Behav; 2019 Apr; 9(4):e01254. PubMed ID: 30859754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the NLRP3 Inflammasome Is Associated with Valosin-Containing Protein Myopathy.
    Nalbandian A; Khan AA; Srivastava R; Llewellyn KJ; Tan B; Shukr N; Fazli Y; Kimonis VE; BenMohamed L
    Inflammation; 2017 Feb; 40(1):21-41. PubMed ID: 27730320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of NLRP3 inflammasome inhibition by MCC950 on LPS-induced pancreatic adenocarcinoma inflammation.
    Yaw ACK; Chan EWL; Yap JKY; Mai CW
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2219-2229. PubMed ID: 32507974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin attenuates secondary brain injury following intracerebral hemorrhage by inhibiting NLRP3 inflammasome activation and promoting Nrf2/ARE signaling pathway in mice.
    Cheng Y; Chen B; Xie W; Chen Z; Yang G; Cai Y; Shang H; Zhao W
    Int Immunopharmacol; 2020 Feb; 79():106180. PubMed ID: 31926478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of NLRP3 inflammasome by MCC950 improves the metabolic outcome of islet transplantation by suppressing IL-1β and islet cellular death.
    Matsuoka T; Yoshimatsu G; Sakata N; Kawakami R; Tanaka T; Yamada T; Yoshida Y; Hasegawa S; Kodama S
    Sci Rep; 2020 Oct; 10(1):17920. PubMed ID: 33087823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FUNDC1 inhibits NLRP3-mediated inflammation after intracerebral hemorrhage by promoting mitophagy in mice.
    Zheng S; Jian D; Gan H; Wang L; Zhao J; Zhai X
    Neurosci Lett; 2021 Jun; 756():135967. PubMed ID: 34022268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson's disease.
    Huang S; Chen Z; Fan B; Chen Y; Zhou L; Jiang B; Long H; Zhong W; Li X; Li Y
    J Neuroimmunol; 2021 May; 354():577543. PubMed ID: 33714750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice.
    Qu J; Yuan Z; Wang G; Wang X; Li K
    Int Immunopharmacol; 2019 May; 70():147-155. PubMed ID: 30802677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.